Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, David Conen, MD, MPH, provides insight into the results of the Swiss Atrial Fibrillation Cohort (Swiss-AF) trial and what they reveal about the incidence of clinically silent brain infarcts...
2013 Summit Co-Chair Edward Shahady, MD, FAACP, ABCL, interviews Louis Kuritzky, MD, on his live session presentation at the conference: "Know Your Options: Pharmacologic and Nonpharmacologic Hypertension...
